FDF&API

Products

Information

Tablets (including cephalosporins), hard capsules (including cephalosporins), Creams (including hormones), liniments, patches, gels, plasters, API (Glucurolactone, Isosorbide Dinitrate, Perphenazine, Clotrimazole, Propantheline Bromide, Sodium Cromoglicate, Pyrazinamide, Thiopride hydrochloride, ciprofloxacin hydrochloride, Flucytosine, Nimodipine, Pyrithioxin Dihydrochloride, silymarin, mexiletine hydrochloride, Bendazol Hydrochloride, Ketotifen Fumarate, Trihexyphenidyl Hydrochloride, Sulfadiazine Silver, Tamoxifen Citrate, Chlorpromazine Hydrochloride, glibenclamide, Furosemide, diammonium glycyrrhizinate, Ezetimibe, Glycopyrronium Bromide, Ipratropium Bromide, L-Malic Acid, Azelastine Hydrochloride)
Beijing Jingfeng Pharmaceutical Group Co., Ltd.​H3.D34Beijing Jingfeng Pharmaceutical Group Co., Ltd.​​ (hereinafter referred to as "the Company") is a wholly-owned subsidiary of Jointown Pharmaceutical Group, focusing on pharmaceutical production and operations, professional incubation, and other health-related industries. Its core business includes generic medicine R&D and pharmaceutical industrial production, covering solid finished formulations, liquid finished formulations, external finished formulations, API synthesis, food additives, and CMO (Contract Manufacturing Organization).